Lincare Holdings Inc. (LNCR): Today's Featured Health Care Loser

Lincare Holdings ( LNCR) pushed the Health Care sector lower today making it today's featured Health Care loser. The sector as a whole closed the day up 2.3%. By the end of trading, Lincare Holdings fell 23 cents (-1%) to $23.20 on heavy volume. Throughout the day, 1.3 million shares of Lincare Holdings exchanged hands as compared to its average daily volume of 695,500 shares. The stock ranged in price between $22.96-$23.51 after having opened the day at $23.43 as compared to the previous trading day's close of $23.43. Other company's within the Health Care sector that declined today were: Fonar Corporation ( FONR), down 14.2%, D Medical Industries ( DMED), down 12.3%, Supernus Pharmaceuticals ( SUPN), down 12.1%, and Dehaier Medical Systems ( DHRM), down 10.4%.

Lincare Holdings Inc. provides oxygen, respiratory, and other chronic therapy services to patients in the home. Lincare Holdings has a market cap of $2.06 billion and is part of the health services industry. The company has a P/E ratio of 12.1, equal to the average health services industry P/E ratio and below the S&P 500 P/E ratio of 17.7. Shares are down 8.9% year to date as of the close of trading on Friday. Currently there are three analysts that rate Lincare Holdings a buy, no analysts rate it a sell, and five rate it a hold.

TheStreet Ratings rates Lincare Holdings as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, growth in earnings per share, notable return on equity, increase in net income and largely solid financial position with reasonable debt levels by most measures. We feel these strengths outweigh the fact that the company shows weak operating cash flow.

On the positive front, Biosante Pharmaceuticals ( BPAX), up 56%, Rosetta Genomics ( ROSG), up 24.7%, Electromed ( ELMD), up 23%, and Peregrine Pharmaceuticals ( PPHM), up 20.5%, were all gainers within the health care sector with Aetna ( AET) being today's featured health care sector winner.

For investors not wanting singular stock exposure, ETFs may be of interest. Investors who are bullish on the health care sector could consider Health Care Select Sector SPDR ( XLV) while those bearish on the health care sector could consider ProShares Ultra Short Health Care ( RXD).